TickerFiles

Arcturus Therapeutics Holdings Inc. 10-K filing

Filed 2026-03-03 · Report date 2025-12-31 · 2025 FY

View Original SEC Filing

Filing metadata

Accession number
0001193125-26-088391
Form type
10-K
CIK
0001768224
Primary document
https://www.sec.gov/Archives/edgar/data/1768224/000119312526088391/arct-20251231.htm

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for Arcturus Therapeutics Holdings Inc..

Reported financial metrics

MetricCurrentPriorChange
Revenue$82.0M--
Operating Income$-76.3M--
Net Income$-65.8M--
Eps Basic-2.4--
Eps Diluted-2.4--
Cash And Equivalents$230.9M--
Total Assets$271.1M--
Total Liabilities$57.2M--
Shareholders Equity$214.0M--
Operating Cash Flow$-74.3M--
Capital Expenditures$230,000--